Dr.Guttler’s Patient Thyroid Blog Post: New Drug for Graves’ Thyroid Eye Disease TED Dr.Guttler’s comments: 1. An editorial on the new drug Teprotumumab for TED. 2. First Food and Drug Administration (FDA)-approved treatment for...
More info
Dr.Guttler’s Patient Thyroid Blog Post: Why Anti-Thyroid Drugs Are The Best Treatment Over Surgery or Radioiodine. Dr.Guttler’s comments: 1. This article reviews results in 4600 Graves’ patients. 2.Patients received ATD...
More info
Dr.Guttler’s comments: 1. Graves’ disease was triggered by the SARS-CoV-2 vaccination. Clinicians need to be vigilant of precipitation or exacerbation of autoimmune thyroid disorders in predisposed individuals after exposure to the...
More info
Runner’s World Cindy Kuzma Mar 18, 2022 Last summer, as he prepared for the 2021 New York City Marathon, interval workouts like 800-meter and mile repeats still went fairly well. On his typically strong tempo and long runs, though, he...
More info
Dr.Guttler’s comments: 1. Study was to assess QoL in patients 6–10 years after treatment for Graves’ disease. 2. Patients treated with RAI had worse thyroid-related and general QoL than patients treated with ATD.Surgery has...
More info
Dr.Guttler’s comments: In 2022 surgery and radioiodine are used less often than long term low dose Anti thyroid drugs. Surgery has it’s own loss of quality of life when complications occur and a scar is left , and life long thyroid...
More info